12:00 AM
Apr 13, 2015
 |  BC Week In Review  |  Company News  |  Deals

Alere Inc, Qiagen deal

Qiagen purchased circulating tumor cell (CTC) detection technology and two diagnostics -- AdnaTest BreastCancer and AdnaTest Prostate Cancer...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >